- Home
- RMCF vs CRIS Comparison
RMCF vs CRIS Comparison
Compare RMCF & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCF
- CRIS
- Stock Information
- Founded
- RMCF 1981
- CRIS 2000
- Country
- RMCF United States
- CRIS United States
- Employees
- RMCF N/A
- CRIS N/A
- Industry
- RMCF Specialty Foods
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RMCF Consumer Staples
- CRIS Health Care
- Exchange
- RMCF Nasdaq
- CRIS Nasdaq
- Market Cap
- RMCF 13.3M
- CRIS 13.5M
- IPO Year
- RMCF N/A
- CRIS 2000
- Fundamental
- Price
- RMCF $1.16
- CRIS $2.00
- Analyst Decision
- RMCF
- CRIS Strong Buy
- Analyst Count
- RMCF 0
- CRIS 3
- Target Price
- RMCF N/A
- CRIS $21.00
- AVG Volume (30 Days)
- RMCF 8.9K
- CRIS 106.4K
- Earning Date
- RMCF 06-12-2025
- CRIS 05-06-2025
- Dividend Yield
- RMCF N/A
- CRIS N/A
- EPS Growth
- RMCF N/A
- CRIS N/A
- EPS
- RMCF N/A
- CRIS N/A
- Revenue
- RMCF $27,939,687.00
- CRIS $11,202,000.00
- Revenue This Year
- RMCF N/A
- CRIS $2.62
- Revenue Next Year
- RMCF N/A
- CRIS $9.84
- P/E Ratio
- RMCF N/A
- CRIS N/A
- Revenue Growth
- RMCF N/A
- CRIS 14.17
- 52 Week Low
- RMCF $1.12
- CRIS $1.02
- 52 Week High
- RMCF $3.59
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- RMCF 37.52
- CRIS 52.24
- Support Level
- RMCF $1.21
- CRIS $1.06
- Resistance Level
- RMCF $1.28
- CRIS $2.45
- Average True Range (ATR)
- RMCF 0.07
- CRIS 0.30
- MACD
- RMCF -0.01
- CRIS 0.02
- Stochastic Oscillator
- RMCF 0.00
- CRIS 36.19
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.